ALB and congestive heart failure: In the weighted cohort, age, sex, SOFA score, albumin, ACC, hemoglobin, RDW, MCV, AST, BUN, creatinine, anion gap, phosphate, comorbidities including congestive heart failure, VF, and malignant tumor, the proportion of receiving norepinephrine, and ICU LOS between survival and non-survival groups were statistically significant (P < 0.05), as shown in Table 1.